Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Buttyan

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Cancer|June 15, 1997
Detection of circulating prostate carcinoma cells via an enhanced reverse transcriptase-polymerase chain reaction assay in patients with early stage prostate carcinoma. Independence from other pretreatment characteristicsR D Ennis, A E Katz, G M de Vries, et al.
Cancer|April 1, 1995
Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancerA E Katz, G M de Vries, M D Begg, et al.
Urology|June 1, 1994
Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assayA E Katz, C A Olsson, A J Raffo, et al.
Oncogene|February 14, 2006
Complex regulation of human androgen receptor expression by Wnt signaling in prostate cancer cellsX Yang, M-W Chen, S Terry, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 1, 1991
Apoptosis: a general commentA Alles, K Alley, J C Barrett, et al.
Urology|August 30, 2000
Blood-based RT-PCR assays of MN/CA9 or PSMA: clinical application in renal cancer patientsA de la Taille, A Katz, Y Cao, et al.
The Prostate|February 7, 2001
Absence of proximal duct apoptosis in the ventral prostate of transgenic mice carrying the C3(1)-TGF-beta type II dominant negative receptorS D Kundu, I Y Kim, T Yang, et al.
Cancer Detection and Prevention|February 24, 2001
Detection of prostate-specific membrane antigen expressing cells in blood obtained from renal cancer patients: a potential biomarker of vascular invasionA de la Taille, Y Cao, I S Sawczuk, et al.
British Journal of Cancer|August 20, 2009
Increased expression of class III beta-tubulin in castration-resistant human prostate cancerS Terry, G Ploussard, Y Allory, et al.
Cancer|August 3, 1999
The detection of renal carcinoma cells in the peripheral blood with an enhanced reverse transcriptase-polymerase chain reaction assay for MN/CA9J M McKiernan, R Buttyan, N H Bander, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Cancer|June 15, 1997
Detection of circulating prostate carcinoma cells via an enhanced reverse transcriptase-polymerase chain reaction assay in patients with early stage prostate carcinoma. Independence from other pretreatment characteristicsR D Ennis, A E Katz, G M de Vries, et al.
Cancer|April 1, 1995
Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancerA E Katz, G M de Vries, M D Begg, et al.
Urology|June 1, 1994
Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assayA E Katz, C A Olsson, A J Raffo, et al.
Oncogene|February 14, 2006
Complex regulation of human androgen receptor expression by Wnt signaling in prostate cancer cellsX Yang, M-W Chen, S Terry, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 1, 1991
Apoptosis: a general commentA Alles, K Alley, J C Barrett, et al.
Urology|August 30, 2000
Blood-based RT-PCR assays of MN/CA9 or PSMA: clinical application in renal cancer patientsA de la Taille, A Katz, Y Cao, et al.
The Prostate|February 7, 2001
Absence of proximal duct apoptosis in the ventral prostate of transgenic mice carrying the C3(1)-TGF-beta type II dominant negative receptorS D Kundu, I Y Kim, T Yang, et al.
Cancer Detection and Prevention|February 24, 2001
Detection of prostate-specific membrane antigen expressing cells in blood obtained from renal cancer patients: a potential biomarker of vascular invasionA de la Taille, Y Cao, I S Sawczuk, et al.
British Journal of Cancer|August 20, 2009
Increased expression of class III beta-tubulin in castration-resistant human prostate cancerS Terry, G Ploussard, Y Allory, et al.
Cancer|August 3, 1999
The detection of renal carcinoma cells in the peripheral blood with an enhanced reverse transcriptase-polymerase chain reaction assay for MN/CA9J M McKiernan, R Buttyan, N H Bander, et al.
Pageof 12